“Real‑life Cost and cost‑effectiveness for Tiotropium 18 μg Od Monotherapy in Moderate and Severe COPD Patients: A 48‑month Survey”. Farmeconomia. Health Economics and Therapeutic Pathways 15, no. 2 (June 30, 2014): 39–44. Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/924.